Page last updated: 2024-08-16

thalidomide and cyclic gmp

thalidomide has been researched along with cyclic gmp in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (50.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Flohé, L; Hennies, HH	1
Anishetty, S; Chatterjee, S; Gupta, R; Ilavarasan, R; Kolluru, GK; Kumar, PG; Majumder, S; Muley, A; Rajaram, M; Reddy, HS; Siamwala, JH; Sinha, S; Sivakumar, KC; Tamilarasan, KP; Venkataraman, S	1

Other Studies

2 other study(ies) available for thalidomide and cyclic gmp

Article	Year
Influence of sedatives on stress-induced trans-synaptic induction of tyrosine hydroxylase. Arzneimittel-Forschung, 1985, Volume: 35, Issue:1 Topics: Adrenal Glands; Animals; Cold Temperature; Cyclic AMP; Cyclic GMP; Diazepam; Enzyme Induction; Humans; Hypnotics and Sedatives; Male; Phenobarbital; Rats; Rats, Inbred Strains; Stress, Psychological; Swimming; Synapses; Thalidomide; Tyrosine 3-Monooxygenase	1985
Thalidomide attenuates nitric oxide-driven angiogenesis by interacting with soluble guanylyl cyclase. British journal of pharmacology, 2009, Volume: 158, Issue:7 Topics: Angiogenesis Inhibitors; Animals; Catalytic Domain; Cattle; Cells, Cultured; Cyclic GMP; Dose-Response Relationship, Drug; Drug Delivery Systems; Endothelial Cells; Endothelium, Vascular; Guanylate Cyclase; Humans; Male; Models, Molecular; Neovascularization, Physiologic; Nitric Oxide; Rats; Rats, Wistar; Receptors, Cytoplasmic and Nuclear; Soluble Guanylyl Cyclase; Thalidomide; Umbilical Veins; Wound Healing	2009

Article

Year

Influence of sedatives on stress-induced trans-synaptic induction of tyrosine hydroxylase.

Arzneimittel-Forschung, 1985, Volume: 35, Issue:1

Topics: Adrenal Glands; Animals; Cold Temperature; Cyclic AMP; Cyclic GMP; Diazepam; Enzyme Induction; Humans; Hypnotics and Sedatives; Male; Phenobarbital; Rats; Rats, Inbred Strains; Stress, Psychological; Swimming; Synapses; Thalidomide; Tyrosine 3-Monooxygenase

1985

Thalidomide attenuates nitric oxide-driven angiogenesis by interacting with soluble guanylyl cyclase.

British journal of pharmacology, 2009, Volume: 158, Issue:7

Topics: Angiogenesis Inhibitors; Animals; Catalytic Domain; Cattle; Cells, Cultured; Cyclic GMP; Dose-Response Relationship, Drug; Drug Delivery Systems; Endothelial Cells; Endothelium, Vascular; Guanylate Cyclase; Humans; Male; Models, Molecular; Neovascularization, Physiologic; Nitric Oxide; Rats; Rats, Wistar; Receptors, Cytoplasmic and Nuclear; Soluble Guanylyl Cyclase; Thalidomide; Umbilical Veins; Wound Healing

2009